Cephalosporin-Aminoglycoside Synergism in Experimental Enterococcal Endocarditis
AUTOR(ES)
Weinstein, Allan J.
RESUMO
Despite in vitro demonstrations of synergism against enterococci, combinations of cephalosporin and aminoglycoside antibodies have been ineffective in the therapy of enterococcal endocarditis. Penicillin-gentamicin, cephalothin-gentamicin, and cefazolin-gentamicin were used to treat enterococcal endocarditis in rabbits. A direct relation was observed between the rate of cure and the degree by which the peak serum concentration of penicillin and the cephalosporins exceeded the minimal inhibitory concentration of the enterococcus. Thus, cephalosporin doses which produce serum concentrations which exceed the minimal inhibitory concentration of the enterococcus by several orders of magnitude may, in combination with aminoglycosides, be effective in treating human enterococcal endocarditis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=429661Documentos Relacionados
- Minimal nephrotoxicity with cephalosporin-aminoglycoside combinations in patients with neoplastic disease.
- Optimal aminoglycoside dosing regimen for penicillin-tobramycin synergism in experimental Streptococcus adjacens endocarditis.
- Ampicillin therapy of experimental enterococcal endocarditis.
- Antimicrobial Therapy of Experimental Enterococcal Endocarditis
- Minimal concentrations of aminoglycoside that can synergize with penicillin in enterococcal endocarditis.
